VuMedi
  • About Us
  • Careers
  • Partner with us
Forgot password?

Login

Login
Forgot your password?
Join VuMedi
  • About Us
  • Careers
  • Partner with us
  • F.A.Q
  • Contact us
  • Terms & conditions
  • Privacy policy

Playback speed

10 seconds

KU ASH 2018 Review: Current Updates in Hematologic Diseases
Avatar

ASH December 2018 - AML - Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies

By KU ASH 2018 Review: Current Updates in Hematologic Diseases FEATURING Elihu H. Estey
By KU ASH 2018 Review: Current Updates in Hematologic Diseases FEATURING Elihu H. Estey
0 views
March 19, 2019
Comments 0
Login to view comments. Click here to Login

Playlist AML - Keynote - Latest updates on Standard Therapies and Investigational Therapies, MRD in AML, HTC and Non-HCT

23:37
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH 2018 AML: Deciding Between Standard vs Investigational Therapies…

Feat. E. Estey
05:54
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - MRD in AML - What is the Benefit / Risk Ratio Re…

Feat. E. Estey
06:26
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - AML - Allogeneic Hematopoietic Cell Transplantat…

Feat. E. Estey
14:49
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH 2018 AML Challenges in Evaluating New Therapies: Understanding t…

Feat. E. Estey
Thumbs Up
  • March 19, 2019

Recommended

AUTOPLAY

  • About Us
  • Careers
  • Partner with us
  • F.A.Q.
  • Contact us
VuMedi

© 2009 - 2025 All rights reserved
Terms & conditions | Privacy policy | Your privacy choices